Delivery Order #SPE2DR26FR0WR

Short-Term Delivery Order for NovoLog Insulin Vials to AmerisourceBergen

This contract is a short-term delivery order awarded under an existing Indefinite Delivery Vehicle (IDV) for pharmaceutical products. The recipient is AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and the holder of the parent IDV contract focused on pharmaceutical services through the Federal Supply Schedule. The awarded contract procures NovoLog 100 unit/mL insulin vials, a critical medication for diabetes management, ensuring availability of this essential product for health agencies. The contract covers the prompt delivery of specified insulin vials within a brief, specified timeframe, supporting public health needs with timely access to life-sustaining drugs. This particular delivery order was awarded competitively under the established IDV, leveraging AmerisourceBergen’s expertise and prior performance in pharmaceutical distribution. The performance period is a few days in early 2026, highlighting a focused, urgent supply requirement fulfilled through this delivery order vehicle.

Description

4570903746!NOVOLOG 100 UNIT/ML VIAL 10ML

View original record